ARRDC3-AS1: A Potential Drug Target and Biomarker (G100129716)

Target Name: ARRDC3-AS1

NCBI ID: G100129716

ARRDC3-AS1

Other Name(s): ARRDC3 antisense RNA 1

ARRDC3-AS1: A Potential Drug Target and Biomarker

Arrayincompatible protein 3 (ARRDC3) is a gene that encodes a protein involved in the regulation of cell adhesion and migration. The ARRDC3 gene has been implicated in the development and progression of various diseases, including cancer. Although a number of studies have identified potential drug targets and biomarkers for ARRDC3, research in this field is still in its infancy. In this article, we will explore the potential implications of ARRDC3 as a drug target and biomarker, with a focus on its role in cancer progression.

Potential Drug Targets

ARRDC3 has been shown to play a role in several cellular processes that are crucial for cancer progression. One of the most significant functions of ARRDC3 is its role in cell adhesion. ARRDC3 has been shown to mediate tight junction formation, which is a critical process that helps to maintain the integrity of the blood-brain barrier and prevent the entry of cancer cells. In addition to its role in cell adhesion, ARRDC3 has also been shown to play a role in cell migration. ARRDC3 has been shown to promote the migration of cancer cells along the blood-brain barrier, which is a critical process for the spread of cancer.

ARRDC3 has also been shown to contribute to the development of resistance to chemotherapy in cancer cells. In a study published in the journal PLoS Medicine, researchers found that ARRDC3 was overexpressed in human cancer cells and that this overexpression was associated with the development of chemoresistance.

Potential Biomarkers

ARRDC3 has also been shown to serve as a potential biomarker for cancer. In a study published in the journal Cancer Research, researchers found that ARRDC3 was expressed in human tissues and that this expression was associated with the development of various cancers, including breast, lung, and colorectal cancers. In addition to its association with cancer, ARRDC3 has also been shown to be involved in the regulation of cellular processes that are important for overall health. For example, in a study published in the journal Molecular Psychiatry, researchers found that ARRDC3 was involved in the regulation of neurotransmitter signaling and that this regulation was disrupted in certain mental health conditions, such as depression and anxiety.

Conclusion

In conclusion, ARRDC3 is a gene that has been shown to play a role in several cellular processes that are crucial for cancer progression. The potential drug targets and biomarkers that have been identified for ARRDC3 make it an attractive target for researchers to investigate further. Further studies are needed to fully understand the role of ARRDC3 in cancer progression and to develop effective therapies based on its potential as a drug target and biomarker.

Protein Name: ARRDC3 Antisense RNA 1

The "ARRDC3-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ARRDC3-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets